1. The Biological and Molecular Function of LINC00665 in Human Cancers
    Cheng Zhang et al, 2022, Frontiers in Oncology CrossRef
  2. The prognostic value and immune landscaps of m6A/m5C-related lncRNAs signature in the low grade glioma
    Ran Li et al, 2023, BMC Bioinformatics CrossRef
  3. A Concise Review on Dysregulation of LINC00665 in Cancers
    Soudeh Ghafouri-Fard et al, 2022, Cells CrossRef
  4. LINC00665: An Emerging Biomarker for Cancer Diagnostics and Therapeutics
    Chenming Zhong et al, 2022, Cells CrossRef
  5. Prognostic and clinicopathological values of LINC00665 in cancers: a systematic review and China population-based meta-analysis
    Ze Jin et al, 2022, Clinical and Experimental Medicine CrossRef
  6. LINC01711 promotes transforming growth factor-beta (TGF-β) induced invasion in glioblastoma multiforme (GBM) by acting as a competing endogenous RNA for miR-34a and promoting ZEB1 expression
    Bakhya Shree et al, 2023, Neuroscience Letters CrossRef
  7. Identification of Ferroptosis-Related Biomarkers for Prognosis and Immunotherapy in Patients With Glioma
    Junfeng Shi et al, 2022, Frontiers in Cell and Developmental Biology CrossRef
  8. Systematic Investigation of the Diagnostic and Prognostic Impact of LINC01087 in Human Cancers
    Fatima Domenica Elisa De Palma et al, 2022, Cancers CrossRef
  9. FOXA1‐induced LINC00621 promotes lung adenocarcinoma progression via activating the TGF‐β signaling pathway
    Jingjing Wei et al, 2023, Thoracic Cancer CrossRef
  10. Screening of Differentially Expressed Genes Based on the ACRG Molecular Subtypes of Gastric Cancer and the Significance and Mechanism of AGTR1 Gene Expression
    Haoran Zhang et al, 2023, Journal of Personalized Medicine CrossRef
  11. The Emerging Roles of LINC00665 in Human Cancers
    Jing Zhu et al, 2022, Frontiers in Cell and Developmental Biology CrossRef
  12. Transforming Growth Factor-Beta-Regulated LncRNA-MUF Promotes Invasion by Modulating the miR-34a Snail1 Axis in Glioblastoma Multiforme
    Bakhya Shree et al, 2022, Frontiers in Oncology CrossRef